We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Robinhood: 7 Years To Build Its Reputations & Less Than 24 Hours To Destroy It
During the market’s most exciting days of trading, millennials’ favorite trading platform was out of commission, leaving 10 million people with no way to buy or sell any assets. For long-term investors on the platform, this wasn’t the end of the world, but for those of us who have a “healthy risk” tolerance and trade options, this lockout was alarming, to say the least.
Yesterday’s rally demolished Robinhood put holders that were unable to liquidate position their positions. Users on Reddit’s Wall Street Bets have been posting their daily losses due to yesterday’s asset freeze with losses ranging from tens of thousands to hundreds of thousands. Many of these users are threatening class action lawsuits.
For more information on the matter, check out the video and read my article: I'm Not Selling...Because Robinhood Won't Let Me
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>